Cocrystal Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) and Cocrystal Pharma (NASDAQ:COCP – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Insider & Institutional Ownership 86.2% of Milestone […]

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the target of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,700 shares, a decline of 31.5% from the February 29th total of 5,400 shares. Approximately 0.1% of the company’s shares are sold short. […]

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 800 shares, a decline of 20.0% from the December 31st total of 1,000 shares. Approximately 0.0% of the company’s stock are sold short. Based on an […]

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the target of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 1,000 shares, a decline of 63.0% from the December 15th total of 2,700 shares. Approximately 0.0% of the shares of the company are […]

Cocrystal Pharma (NASDAQ:COCP – Free Report) had its price target decreased by HC Wainwright from $12.00 to $10.00 in a research report released on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Cocrystal Pharma’s Q4 2023 earnings at ($0.58) EPS, FY2023 earnings at ($2.01) […]